BMA Stock Analysis: Buy, Sell, or Hold?

BMA - Banco Macro S.A.

Commercial Banks, NEC
$101.90
-1.05 (-1.02%) ▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026 24d

Get Alerted When BMA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: BMA shows positive signals but monitor for confirmation. Market pricing in 14.0% growth. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$549957.86
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$341480.56
100.0% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BMA is currently trading at $101.90, which is considered extended relative to its 30-day fair value range of $89.57 to $99.06. At these levels, the market is pricing in 14.0% annual earnings growth.

Technical Outlook: Technically, BMA is in a strong uptrend. Immediate support is located at $89.98, while resistance sits at $106.15.

Market Sentiment: BMA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $89.57 - $99.06
Company Quality Score 64/100 (BUY)
Volume Confirmation HIGH
Confidence Score 68.1%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($112.03)
  • BULLISH: Expecting earnings turnaround to 14.0% growth with -28.7% revenue growth

Fair Price Analysis

30-Day Fair Range $89.57 - $99.06
Current vs Fair Value EXTENDED
Expected Move (7 Days) ±$9.06 (8.9%)

Support & Resistance Levels

Support Level $89.98
Resistance Level $106.15
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 0.01
Wall Street Target $112.03 (+8.8%)
Revenue Growth (YoY) -28.7%
Earnings Growth (YoY) -89.6%
Profit Margin 8.6%
Valuation Premium vs History +14.0% premium
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +14.0% (market-implied from PE analysis)
1-Year Target $117.36 (+14%)
2-Year Target $133.79 (+30%)
3-Year Target $152.52 (+48%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 32.3%) $728798.93 (+707815%)
Base: (SPY PE: 0.0, Growth: 32.3%) $238.27 (+131%)
Bear: (PE: 0.0, Growth: 32.3%) $202.53 (+97%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (42x PE), but valuation improves significantly next year (0x PE) as earnings recover.
Trailing PE: 41.73 | Current EPS (TTM): $2.49
Bull Case $228.60 (+124%)
Analyst growth 100.0%, PE expands to 45.9
Base Case $207.82 (+104%)
Market implied 100.0%, PE stable at 41.7
Bear Case $70.66 (-31%)
Severe decline -20.0%, PE contracts to 35.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 9:14 AM ET
Data refreshes hourly during market hours. Next update: 10:14 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Banks - Regional Stocks

Top-rated stocks in Banks - Regional by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
USB
U.S. Bancorp
BUY
24 analysts
$62 63 BUY
FITB
Fifth Third Bancorp
BUY
24 analysts
$56 63 BUY
HBAN
Huntington Bancshares In…
STRONG BUY
21 analysts
$20 58 HOLD
WBS
Webster Financial Corpor…
STRONG BUY
16 analysts
$75 59 HOLD
CFG
Citizens Financial Group…
BUY
21 analysts
$71 59 HOLD

Advanced BMA Option Strategies

Professional options setups generated by AI based on today's BMA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BMA

BMA Technical Chart BMA Price Prediction BMA Earnings Date BMA Investment Advisor BMA Fair Price Analyzer BMA Options Advisor BMA Options Chain BMA Options Analysis BMA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals